Role of type 1 natural killer T cells in pulmonary immunity

Mucosal Immunology

Volumn 6, Issue 6, 2013, Pages 1054-1067

  Paget, C ^a,b,c,d,e,f   Trottein, F ^c,d,e,f  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c INSERM U1019   (France)

^d INSERM   (France)

^e UNIV LILLE   (France)

^f Institut Federatif de Recherche 142   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN B; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

ACUTE LUNG INJURY; ASTHMA; BRONCHUS HYPERREACTIVITY; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHLAMYDIAL PNEUMONIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROHN DISEASE; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLUENZA; INNATE IMMUNITY; LEGIONNAIRE DISEASE; LUNG ASPERGILLOSIS; LUNG FIBROSIS; LUNG INFECTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; LYMPHOPOIESIS; MOLECULAR RECOGNITION; NATURAL KILLER T CELL; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; PULMONARY CRYPTOCOCCOSIS; PULMONARY IMMUNITY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT PARAMETERS; REVIEW; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIA; TUBERCULOSIS; TYPE 1 NATURAL KILLER T CELL; TYPE 2 NATURAL KILLER T CELL; ULCERATIVE COLITIS; UROGENITAL SYSTEM;

ANIMALS; CYTOKINES; ENVIRONMENTAL EXPOSURE; HUMANS; IMMUNOSUPPRESSION; IMMUNOTHERAPY, ADOPTIVE; LUNG; MUCOUS MEMBRANE; NATURAL KILLER T-CELLS; PNEUMONIA; RESPIRATORY TRACT INFECTIONS;

EID: 84886003120     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2013.59     Document Type: Review

References (185)

1. Bendelac, A., Savage, P.B. & Teyton, L. The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
2. Cohen, N.R., Garg, S. & Brenner, M.B. Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity. Adv. Immunol. 102, 1-94 (2009).
3. Godfrey, D.I. & Kronenberg, M. Going both ways: Immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114, 1379-1388 (2004).
4. Matsuda, J.L., Mallevaey, T., Scott-Browne, J. & Gapin, L. CD1drestricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr. Opin. Immunol. 20, 358-368 (2008).
5. Rhost, S., Sedimbi, S., Kadri, N. Cardell, S.L. Immunomodulatory type II natural killer T lymphocytes in health and disease. Scand. J. Immunol. 76, 246-255 (2012).
6. Rossjohn, J., Pellicci, D.G., Patel, O., Gapin, L. & Godfrey, D.I. Recognition of CD1d-restricted antigens by natural killer T cells. Nat. Rev. Immunol. 12, 845-857 (2012).
7. Berzofsky, J.A. & Terabe, M. The contrasting roles of NKT cells in tumor immunity. Curr. Mol. Med. 9, 667-672 (2009).
8. Uldrich, A.P. et al. A semi-invariant Valpha10+ T cell antigen receptor defines a population of natural killer Tcells with distinct glycolipid antigenrecognition properties. Nat. Immunol. 12, 616-623 (2011).
9. Godfrey, D.I., Stankovic, S. & Baxter, A.G. Raising the NKTcell family. Nat. Immunol. 11, 197-206 (2010).
10. Olszak, T. et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 336, 489-493 (2012).
11. Wingender, G. et al. Intestinal microbes affect phenotypes and functions of invariant natural killer T cells in mice. Gastroenterology 143, 418-428 (2012).
12. Lynch, L., O'Shea, D., Winter, D.C., Geoghegan, J., Doherty, D.G. & O'Farrelly, C. Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity. Eur. J. Immunol. 39, 1893-1901 (2009).
13. Scanlon, S.T. et al. Airborne lipid antigens mobilize resident intravascular NKT cells to induce allergic airway inflammation. J. Exp. Med. 208, 2113-2124 (2011).
14. Mutalithas, K. et al. Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma. J. Allergy Clin. Immunol. 119, 1274-1276 (2007).
15. Vijayanand, P. et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J.Med. 356, 1410-1422 (2007).
16. Kawano, T. et al. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278, 1626-1629 (1997).
17. Carnaud, C et al. Cutting edge: Cross-Talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163, 4647-4650 (1999).
18. De Santo, C. et al. Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat. Immunol. 11, 1039-1046 (2010).
19. Galli, G. et al. Invariant NKT cells sustain specific B cell responses and memory. Proc. Natl Acad. Sci. USA 104, 3984-3989 (2007).
20. Nieuwenhuis, E.E. et al. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat. Med. 8, 588-593 (2002).
21. Paget, C., Chow, M.T., Duret, H., Mattarollo, S.R. & Smyth, M.J. Role of gammadelta T cells in alpha-galactosylceramide-mediated immunity. J. Immunol. 188, 3928-3939 (2012).
22. Singh, N. et al. Cutting edge: Activation of NK Tcells by CD1d and alphagalactosylceramide directs conventional Tcells to the acquisition of a Th2 phenotype. J. Immunol. 163, 2373-2377 (1999).
23. Wingender, G., Krebs, P., Beutler, B. & Kronenberg, M. Antigen-specific cytotoxicity by invariant NKTcells in vivo is CD95/CD178-dependent and is correlated with antigenic potency. J. Immunol. 185, 2721-2729 (2010).
24. Hongo, D., Tang, X., Dutt, S., Nador, R.G. & Strober, S. Interactions between NKTcells and Tregs are required for tolerance to combined bone marrow and organ transplants. Blood 119, 1581-1589 (2012).
25. Iwai, T. et al. Regulatory roles of NKT cells in the induction and maintenance of cyclophosphamide-induced tolerance. J. Immunol. 177, 8400-8409 (2006).
26. Roelofs-Haarhuis, K., Wu, X. & Gleichmann, E. Oral tolerance to nickel requires CD4+ invariant NKTcells for the infectious spread of tolerance and the induction of specific regulatory T cells. J. Immunol. 173, 1043-1050 (2004).
27. Watte, C.M., Nakamura, T., Lau, C.H., Ortaldo, J.R. & Stein-Streilein, J. Ly49 C/I-dependent NKT cell-derived IL-10 is required for corneal graft survival and peripheral tolerance. J. Leukoc. Biol. 83, 928-935 (2008).
28. Tupin, E., Kinjo, Y. & Kronenberg, M. The unique role of natural killer Tcells in the response to microorganisms. Nat. Rev. Microbiol. 5, 405-417 (2007).
29. Crowe, N.Y. et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J. Exp. Med. 202, 1279-1288 (2005).
30. Gumperz, J.E., Miyake, S., Yamamura, T. & Brenner, M.B. Functionally distinct subsets of CD1d-restricted natural killer Tcells revealed by CD1d tetramer staining. J. Exp. Med. 195, 625-636 (2002).
31. Stock, P., Lombardi, V., Kohlrautz, V. & Akbari, O. Induction of airway hyperreactivity by IL-25 is dependent on a subset of invariant NKT cells expressing IL-17RB. J. Immunol. 182, 5116-5122 (2009).
32. Terashima, A. et al. A novel subset of mouse NKTcells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J. Exp. Med. 205, 2727-2733 (2008).
33. Coquet, J.M. et al. Diverse cytokine production by NKTcell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population. Proc. Natl Acad. Sci. USA 105, 11287-11292 (2008).
34. Michel, M.L. et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204, 995-1001 (2007).
35. Doisne, J.M. et al. Skin and peripheral lymph node invariant NKTcells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J. Immunol. 183, 2142-2149 (2009).
36. Doisne, J.M. et al. Cutting edge: Crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J. Immunol. 186, 662-666 (2011).
37. Paget, C. et al. Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: Potential role in protection against lung epithelial damages. J. Biol. Chem. 287, 8816-8829 (2012).
38. Dubin, P.J. & Kolls, J.K. Th17 cytokines and mucosal immunity. Immunol. Rev. 226, 160-171 (2008).
39. Berzins, S.P., Smyth, M.J. & Baxter, A.G. Presumed guilty: Natural killer T cell defects and human disease. Nat. Rev. Immunol. 11, 131-142 (2011).
40. Karadimitris, A. & Chaidos, A. The role of invariant NKTcells in allogeneic hematopoietic stem cell transplantation. Crit. Rev. Immunol. 32, 157-171 (2012).
41. Latour, S. Natural killer Tcells and X-linked lymphoproliferative syndrome. Curr. Opin. Allergy Clin. Immunol. 7, 510-514 (2007).
42. Wu, L. & Van Kaer, L. Role of NKT cells in the digestive system. II. NKT cells and diabetes. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G919-G922 (2007).
43. Motohashi, S., Okamoto, Y., Yoshino, I. & Nakayama, T. Anti-Tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer. Clin. Immunol. 140, 167-176 (2011).
44. Schneiders, F.L. et al. Clinical experience with alpha-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection. Clin. Immunol. 140, 130-141 (2011).
45. Exley, M.A. & Nakayama, T. NKT-cell-based immunotherapies in clinical trials. Clin. Immunol. 140, 117-118 (2011).
46. Metelitsa, L.S. Anti-Tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans. Clin. Immunol. 140, 119-129 (2011).
47. Cerundolo, V., Silk, J.D., Masri, S.H. & Salio,M. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9, 28-38 (2009).
48. Venkataswamy, M.M. et al. Incorporation of NKTcell-Activating glycolipids enhances immunogenicity and vaccine efficacy of Mycobacterium bovis bacillus Calmette-Guerin. J. Immunol. 183, 1644-1656 (2009).
49. Faveeuw, C.,Mallevaey, T.& Trottein, F. Role of natural killer T lymphocytes during helminthic infection. Parasite 15, 384-388 (2008).
50. Tessmer, M.S., Fatima, A., Paget, C., Trottein, F. & Brossay, L. NKT cell immune responses to viral infection. Expert Opin. Ther. Targets 13, 153-162 (2009).
51. Scott-Browne, J.P. et al. Germline-encoded recognition of diverse glycolipids by natural killer T cells. Nat. Immunol. 8, 1105-1113 (2007).
52. Kinjo, Y. et al. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat. Immunol. 12, 966-974 (2011).
53. Kinjo, Y. et al. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7, 978-986 (2006).
54. Kinjo, Y. et al. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525 (2005).
55. Mattner, J. et al. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529 (2005).
56. Sriram, V., Du, W., Gervay-Hague, J. & Brutkiewicz, R.R. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35, 1692-1701 (2005).
57. Fischer, K. et al. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted Tcells. Proc.Natl Acad. Sci. USA 101, 10685-10690 (2004).
58. Brigl, M. & Brenner, M.B. How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens. Semin. Immunol. 22, 79-86 (2010).
59. Brigl, M., Bry, L., Kent, S.C., Gumperz, J.E. & Brenner, M.B. Mechanism of CD1d-restricted natural killer Tcell activation during microbial infection. Nat. Immunol. 4, 1230-1237 (2003).
60. Brigl, M. et al. Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection. J. Exp. Med. 208, 1163-1177 (2011).
61. Darmoise, A. et al. Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer Tcells. Immunity 33, 216-228 (2010).
62. Paget, C. et al. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27, 597-609 (2007).
63. Salio, M. et al. Modulation of human natural killer T cell ligands on TLRmediated antigen-presenting cell activation. Proc. Natl Acad. Sci. USA 104, 20490-20495 (2007).
64. Paget, C. et al. Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides. J. Immunol. 182, 1846-1853 (2009).
65. Brennan, P.J. et al. Invariant natural killer Tcells recognize lipid self antigen induced by microbial danger signals. Nat. Immunol. 12, 1202-1211 (2011).
66. Pellicci, D.G. et al. Recognition of beta-linked self glycolipidsmediated by natural killer T cell antigen receptors. Nat. Immunol. 12, 827-833 (2011).
67. Wu, D.Y., Segal, N.H., Sidobre, S., Kronenberg, M. & Chapman, P.B. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198, 173-181 (2003).
68. Fox, L.M. et al. Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol. 7, e1000228 (2009).
69. Venkataswamy, M.M. & Porcelli, S.A. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Semin. Immunol. 22, 68-78 (2010).
70. Zeissig, S. et al. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat. Med. 18, 1060-1068 (2012).
71. Ronet, C. et al. NKT cells are critical for the initiation of an inflammatory bowel response against Toxoplasma gondii. J. Immunol. 175, 899-908 (2005).
72. Bannai, M. et al. Abundance of unconventional CD8(+) natural killer T cells in the large intestine. Eur. J. Immunol. 31, 3361-3369 (2001).
73. Fuss, I.J. et al. Nonclassical CD1d-restrictedNKTcells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 113, 1490-1497 (2004).
74. Iiai, T., Watanabe, H., Suda, T., Okamoto, H., Abo, T. & Hatakeyama, K. CD161+ T (NT) cells exist predominantly in human intestinal epithelium as well as in liver. Clin. Exp. Immunol. 129, 92-98 (2002).
75. O'Keeffe, J. et al. Diverse populations of T cells with NK cell receptors accumulate in the human intestine in health and in colorectal cancer. Eur. J. Immunol. 34, 2110-2119 (2004).
76. Kim, H.J., Hwang, S.J., Kim, B.K., Jung, K.C. & Chung, D.H. NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells. Immunology 118, 101-111 (2006).
77. Rajavelu,P., Rayapudi, M., Moffitt, M.,Mishra, A. Mishra, A. Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G645-G654 (2012).
78. Jyonouchi, S. et al. Invariant natural killer Tcells from children with versus without food allergy exhibit differential responsiveness to milk-derived sphingomyelin. J. Allergy Clin. Immunol. 128, 102-109 e113 (2011).
79. Ulanova, M. et al. Expression of CD1d in the duodenum of patients with cow's milk hypersensitivity. Scand. J. Immunol. 52, 609-617 (2000).
80. Wingender, G. & Kronenberg, M. Role of NKTcells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 294, G1-G8 (2008).
81. Zeissig, S., Kaser, A., Dougan, S.K., Nieuwenhuis, E.E. & Blumberg, R.S. Role of NKTcells in the digestive system. III. Role of NKTcells in intestinal immunity. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1101-G1105 (2007).
82. Arrunategui-Correa, V. & Kim, H.S. The role of CD1d in the immune response against Listeria infection. Cell Immunol. 227, 109-120 (2004).
83. Emoto, M., Yoshizawa, I., Emoto, Y., Miamoto, M., Hurwitz, R. & Kaufmann, S.H. Rapid development of a gamma interferon-secreting glycolipid/CD1d-specific Valpha14+ NK1.1- T-cell subset after bacterial infection. Infect. Immun. 74, 5903-5913 (2006).
84. Ranson, T. et al. Invariant V alpha 14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection. J. Immunol. 175, 1137-1144 (2005).
85. Smiley, S.T. et al. Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice. J. Immunol. 174, 7904-7911 (2005).
86. Wilson, M.T. et al. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl Acad. Sci. USA 100, 10913-10918 (2003).
87. Ashkar, A.A. & Rosenthal, K.L. Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J. Virol. 77, 10168-10171 (2003).
88. Jiang, J. et al. Interruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection. PloS ONE 7, e47487 (2012).
89. Wang, H. et al. Protective role of alpha-galactosylceramide-stimulated natural killer T cells in genital tract infection with Chlamydia muridarum. FEMS Immunol. Med. Microbiol. 65, 43-54 (2012).
90. Holtzman, M.J. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J. Clin. Invest. 122, 2741-2748 (2012).
91. Holgate, S.T. Innate and adaptive immune responses in asthma. Nat. Med. 18, 673-683 (2012).
92. Chuang, Y.H., Wang, T.C., Jen, H.Y., Yu, A.L. & Chiang, B.L. alpha-Galactosylceramide-induced airway eosinophilia is mediated through the activation of NKT cells. J. Immunol. 186, 4687-4692 (2011).
93. Matangkasombut, P. et al. Natural killer Tcells in the lungs of patients with asthma. J. Allergy Clin. Immunol. 123, 1181-1185 (2009).
94. Meyer, E.H. et al. Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. Proc. Natl Acad. Sci. USA 103, 2782-2787 (2006).
95. Renukaradhya, G.J. et al. Functional invariant NKT cells in pig lungs regulate the airway hyperreactivity: A potential animal model. J. Clin. Immunol. 31, 228-239 (2011).
96. Pichavant, M. et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer Tcells and IL-17. J. Exp. Med. 205, 385-393 (2008).
97. Kim, E.Y. et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14, 633-640 (2008).
98. Akbari, O. et al. Essential role of NKTcells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9, 582-588 (2003).
99. Lisbonne, M. et al. Cutting edge: Invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171, 1637-1641 (2003).
100. Lombardi, V. et al. A CD1d-dependent antagonist inhibits the activation of invariant NKTcells and prevents development of allergen-induced airway hyperreactivity. J. Immunol. 184, 2107-2115 (2010).
101. Das, J. et al. Natural killer Tcells and CD8+ Tcells are dispensable for T cell-dependent allergic airway inflammation. Nat. Med. 12, 1345-1346 (2006). author reply 1347.
102. Williams, L.K., Ownby, D.R., Maliarik, M.J. & Johnson, C.C. The role of endotoxin and its receptors in allergic disease. Ann. Allergy Asthma Immunol. 94, 323-332 (2005).
103. Wingender, G. et al. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J. Exp. Med. 208, 1151-1162 (2011).
104. Agea, E. et al. Human CD1-restricted T cell recognition of lipids from pollens. J. Exp. Med. 202, 295-308 (2005).
105. Nagata, Y., Kamijuku, H., Taniguchi,M., Ziegler, S. & Seino, K. Differential role of thymic stromal lymphopoietin in the induction of airway hyperreactivity and Th2 immune response in antigen-induced asthma with respect to natural killer Tcell function. Int. Arch. Allergy Immunol. 144, 305-314 (2007).
106. Bourgeois, E. et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 39, 1046-1055 (2009).
107. Smithgall, M.D., Comeau, M.R., Yoon, B.R., Kaufman, D., Armitage, R. & Smith,D.E. IL-33 amplifies both Th1- And Th2-Type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 20, 1019-1030 (2008).
108. Fujita, H. et al. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model. J. Immunol. 183, 254-260 (2009).
109. Hachem, P. et al. Alpha-galactosylceramide-induced iNKTcells suppress experimental allergic asthma in sensitized mice: Role of IFN-gamma. Eur. J. Immunol. 35, 2793-2802 (2005).
110. Matsuda, H. et al. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation. Am. J. Respir.Cell Mol.Biol. 33, 22-31 (2005).
111. Morishima, Y. et al. Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. Eur. J. Immunol. 35, 2803-2814 (2005).
112. Horani, A. et al. Immune modulation of ovalbumin-induced lung injury in mice using beta-glucosylceramide and a potential role of the liver. Immunobiology 216, 548-557 (2011).
113. Grela, F. et al. The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma. J. Immunol. 186, 284-290 (2011).
114. Chang, Y.J. et al. Influenza infection in suckling mice expands an NKTcell subset that protects against airway hyperreactivity. J. Clin. Invest. 121, 57-69 (2011).
115. Iwamura, C. & Nakayama, T. Role of NKT cells in allergic asthma. Curr. Opin. Immunol. 22, 807-813 (2010).
116. Thomas, S.Y., Chyung, Y.H. & Luster, A.D. Natural killer Tcells are not the predominant T cell in asthma and likely modulate, not cause, asthma. J. Allergy Clin. Immunol. 125, 980-984 (2010).
117. Umetsu, D.T. & Dekruyff, R.H. Natural killer T cells are important in the pathogenesis of asthma: The many pathways to asthma. J. Allergy Clin. Immunol. 125, 975-979 (2010).
118. Akbari, O. et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N. Engl. J. Med. 354, 1117-1129 (2006).
119. Brooks, C.R., Weinkove, R., Hermans, I.F., van Dalen, C.J. & Douwes, J. Invariant natural killer T cells and asthma: Immunologic reality or methodologic artifact? J. Allergy Clin. Immunol. 126, 882-885 (2010).
120. Hamzaoui, A. et al. NKTcells in the induced sputum of severe asthmatics. Mediators Inflamm. 2006, 71214 (2006).
121. Koh, Y.I. et al. Natural killer T cells are dispensable in the development of allergen-induced airway hyperresponsiveness, inflammation and remodelling in a mouse model of chronic asthma. Clin. Exp. Immunol. 161, 159-170 (2010).
122. Matangkasombut, P. et al. Direct activation of natural killer Tcells induces airway hyperreactivity in nonhuman primates. J. Allergy Clin. Immunol. 121, 1287-1289 (2008).
123. Pham-Thi, N., de Blic, J., Le Bourgeois, M., Dy, M., Scheinmann, P. & Leite-de-Moraes, M.C. Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma. J. Allergy Clin. Immunol. 117, 217-218 (2006).
124. Reynolds, C. et al. Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma. J. Allergy Clin. Immunol. 124, 860-862 (2009). author reply 862.
125. Thomas, S.Y., Lilly, C.M. & Luster, A.D. Invariant natural killer T cells in bronchial asthma. N. Engl. J. Med. 354, 2613-2616. author reply 2613-2616 (2006).
126. Barnes, P.J. Chronic obstructive pulmonary disease. N. Engl. J. Med. 343, 269-280 (2000).
127. Lopez, A.D. et al. Chronic obstructive pulmonary disease: Current burden and future projections. Eur. Respir. J. 27, 397-412 (2006).
128. Mannino, D.M. & Buist, A.S. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 370, 765-773 (2007).
129. Aoyagi, T. et al. Activation of pulmonary invariant NKT cells leads to exacerbation of acute lung injury caused by LPS through local production of IFN-gamma and TNF-Alpha by Gr-1+ monocytes. Int. Immunol. 23, 97-108 (2011).
130. Kim, J.H. & Chung, D.H. CD1d-restricted IFN-gamma-secreting NKT cells promote immune complex-induced acute lung injury by regulating macrophage-inflammatory protein-1alpha production and activation of macrophages and dendritic cells. J. Immunol. 186, 1432-1441 (2011).
131. Wallace, K.L. et al. NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFNgamma and CXCR3 chemokines. Blood 114, 667-676 (2009).
132. Wallace, K.L. & Linden, J. Adenosine A2A receptors induced on iNKTand NK cells reduce pulmonary inflammation and injury inmice with sickle cell disease. Blood 116, 5010-5020 (2010).
133. Kimura, T. et al. Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis. J. Immunol. 172, 5782-5789 (2004).
134. Horikawa, M. et al. E- And P-selectins synergistically inhibit bleomycininduced pulmonary fibrosis. Am. J. Pathol. 169, 740-749 (2006).
135. Kim, J.H., Kim, H.Y., Kim, S., Chung, J.H., Park, W.S. & Chung, D.H. Natural killer T (NKT) cells attenuate bleomycin-induced pulmonary fibrosis by producing interferon-gamma. Am. J. Pathol. 167, 1231-1241 (2005).
136. Hwang, S.J., Kim, S., Park,W.S. & Chung, D.H. IL-4-secreting NKTcells prevent hypersensitivity pneumonitis by suppressing IFN-gamma-producing neutrophils. J. Immunol. 177, 5258-5268 (2006).
137. Johnson, T.R., Hong, S., Van Kaer, L., Koezuka, Y. & Graham, B.S. NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus. J. Virol. 76, 4294-4303 (2002).
138. Monto, A.S. Epidemiology of influenza. Vaccine 26 (Suppl 4), D45-D48 (2008).
139. Palese, P. Influenza: Old and new threats. Nat. Med. 10 (12 Suppl), S82-S87 (2004).
140. Hartshorn, K.L. New look at an old problem: Bacterial superinfection after influenza. Am. J. Pathol. 176, 536-539 (2010).
141. Morens, D.M., Taubenberger, J.K. & Fauci, A.S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness. J. Infect. Dis. 198, 962-970 (2008).
142. Ho, L.P., Denney, L., Luhn, K., Teoh, D., Clelland, C. & McMichael, A.J. Activation of invariant NKT cells enhances the innate immune response and improves the disease course in influenza A virus infection. Eur. J. Immunol. 38, 1913-1922 (2008).
143. Kok,W.L. et al. Pivotal Advance: Invariant NKTcells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection. J. Leukoc. Biol. 91, 357-368 (2012).
144. Guillonneau, C. et al. Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proc. Natl Acad. Sci. USA 106, 3330-3335 (2009).
145. Kamijuku, H. et al. Mechanism of NKT cell activation by intranasal coadministration of alpha-galactosylceramide, which can induce cross-protection against influenza viruses. Mucosal Immunol. 1, 208-218 (2008).
146. Kopecky-Bromberg, S.A. et al. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine 27, 3766-3774 (2009).
147. Li, K., Luo, J., Wang, C. & He, H. alpha-Galactosylceramide potently augments M2e-induced protective immunity against highly pathogenic H5N1 avian influenza virus infection in mice. Vaccine 29, 7711-7717 (2011).
148. Youn, H.J. et al. A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-Term protective immunity without redirecting antigen to the central nervous system. Vaccine 25, 5189-5198 (2007).
149. De Santo, C. et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J. Clin. Invest. 118, 4036-4048 (2008).
150. Maazi, H. et al. Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection. PloS ONE 8, e59599 (2013).
151. Paget, C. et al. Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia. J. Immunol. 186, 5590-5602 (2011).
152. Abdul-Careem, M.F. et al. Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J. Infect. Dis. 206, 167-177 (2012).
153. Zhou, G., Juang, S.W. & Kane, K.P. NK cells exacerbate the pathology of influenza virus infection in mice. Eur. J. Immunol. 43, 929-938 (2013).
154. Aldridge, J.R. Jr et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl Acad. Sci. USA 106, 5306-5311 (2009).
155. Ivanov, S. et al. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. J. Virol. 87, 6911-6924 (2013).
156. Kumar, P., Thakar, M.S., Ouyang, W. & Malarkannan, S. IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection. Mucosal Immunol. 6, 69-82 (2013).
157. Pociask, D.A. et al. IL-22 is essential for lung epithelial repair following influenza infection. Am. J. Pathol. 182, 1286-1296 (2013).
158. van der Poll, T. & Opal, S.M. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374, 1543-1556 (2009).
159. Kawakami, K. et al. Critical role of Valpha14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection. Eur. J. Immunol. 33, 3322-3330 (2003).
160. Nakamatsu, M. et al. Role of interferon-gamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. Microbes Infect. 9, 364-374 (2007).
161. Ivanov, S. et al. Key role for respiratory CD103(+) dendritic cells, IFNgamma, and IL-17 in protection against Streptococcus pneumoniae infection in response to alpha-galactosylceramide. J Infect. Dis. 206, 723-734 (2012).
162. Kinjo, T. et al. NKTcells play a limited role in the neutrophilic inflammatory responses and host defense to pulmonary infection with Pseudomonas aeruginosa. Microbes Infect. 8, 2679-2685 (2006).
163. Rieder, S.A., Nagarkatti, P. & Nagarkatti, M. CD1d-independent activation of invariant natural killer T cells by Staphylococcal enterotoxin B through major histocompatibility complex class II/T cell receptor interaction results in acute lung injury. Infect. Immun. 79, 3141-3148 (2011).
164. Ragin, M.J., Sahu, N. & August, A. Differential regulation of cytokine production by CD1d-restricted NKT cells in response to superantigen staphylococcal enterotoxin B exposure. Infect. Immun. 74, 282-288 (2006).
165. Hayworth, J.L., Mazzuca, D.M., Maleki Vareki, S., Welch, I., McCormick, J.K. & Haeryfar, S.M. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens. Immunol. Cell Biol. 90, 699-709 (2012).
166. Bilenki, L., Wang, S., Yang, J., Fan, Y., Joyee, A.G. & Yang, X. NK T cell activation promotes Chlamydia trachomatis infection in vivo. J. Immunol. 175, 3197-3206 (2005).
167. Joyee, A.G., Qiu, H.,Wang, S., Fan, Y., Bilenki, L. & Yang, X. Distinct NKT cell subsets are induced by different Chlamydia species leading to differential adaptive immunity and host resistance to the infections. J. Immunol. 178, 1048-1058 (2007).
168. Yang, X. Natural killer T (NKT) cell subsets in chlamydial infections. Adv. Exp. Med. Biol. 601, 243-246 (2007).
169. Hayakawa, K. et al. Paradoxically high resistance of natural killer T (NKT) cell-deficient mice to Legionella pneumophila: Another aspect of NKT cells for modulation of host responses. J. Med. Microbiol. 57 (Pt 11), 1340-1348 (2008).
170. Behar, S.M., Dascher, C.C., Grusby, M.J., Wang, C.R. & Brenner, M.B. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189, 1973-1980 (1999).
171. Sada-Ovalle, I., Chiba, A., Gonzales, A., Brenner, M.B. & Behar, S.M. Innate invariant NKT cells recognize Mycobacterium tuberculosisinfected macrophages, produce interferon-gamma, and kill intracellular bacteria. PLoS Pathogens 4, e1000239 (2008).
172. Skold, M. & Behar, S.M. Role of CD1d-restricted NKT cells in microbial immunity. Infect. Immun. 71, 5447-5455 (2003).
173. Sousa, A.O. et al. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice. Proc. Natl Acad. Sci. USA 97, 4204-4208 (2000).
174. Szalay,G., Zugel, U., Ladel,C.H. & Kaufmann, S.H. Participation of group 2 CD1 molecules in the control ofmurine tuberculosis. Microbes Infect. 1, 1153-1157 (1999).
175. Chackerian, A., Alt, J., Perera, V. & Behar, S.M. Activation of NKT cells protects mice from tuberculosis. Infect. Immun. 70, 6302-6309 (2002).
176. Chiba, A., Dascher, C.C., Besra, G.S. & Brenner, M.B. Rapid NKT cell responses are self-Terminating during the course of microbial infection. J. Immunol. 181, 2292-2302 (2008).
177. Dieli, F. et al. An anti-inflammatory role for V alpha 14 NK T cells in Mycobacterium bovis bacillus Calmette-Guerin-infected mice. J. Immunol. 171, 1961-1968 (2003).
178. Im, J.S. et al. Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infections. Clin. Immunol. 127, 214-224 (2008).
179. Montoya, C.J., Catano, J.C., Ramirez, Z., Rugeles, M.T., Wilson, S.B. & Landay, A.L. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin. Immunol. 127, 1-6 (2008).
180. Sutherland, J.S. et al. High granulocyte/lymphocyte ratio and paucity of NKT cells defines TB disease in a TB-endemic setting. Tuberculosis 89, 398-404 (2009).
181. Veenstra, H. et al. Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders. Clin. Exp. Immunol. 145, 252-260 (2006).
182. Kawakami, K. et al. Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKTcells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J. Immunol. 167, 6525-6532 (2001).
183. Kawakami, K. et al. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host
184. Cohen, N.R. et al. Innate recognition of cell wall beta-glucans drives invariant natural killer Tcell responses against fungi. CellHost Microbe 10, 437-450 (2011).
185. Park, J.E. et al. Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand. Immunology 123, 145-155 (2008).